Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Anti-Human CEACAM 8/CD66b Reference Antibody (Besilesomab, RUO)


View Antibody details

Anti-Human CEACAM-1/CD66a Recombinant Antibody (SAA0761)


View Antibody details

Anti-Human CEACAM-1/CD66a Reference Antibody (CM-24, RUO)


View Antibody details

Anti-Human CEACAM-1/CD66a Reference Antibody (MK-6018, RUO)


View Antibody details

Anti-Human CEACAM-5/CD66e & CD3 Bispecific Reference Antibody (MEDI-565, RUO)


View Antibody details

Anti-Human CEACAM-5/CD66e & CD3 epsilon Bispecific Reference Antibody (Cibisatamab, RUO)


View Antibody details

Anti-Human CEACAM-5/CD66e Recombinant Antibody (78NCA-90)


View Antibody details

Anti-Human CEACAM-5/CD66e Recombinant Antibody (MN14)


View Antibody details

Anti-Human CEACAM-5/CD66e Recombinant Antibody (RG7813)


View Antibody details

Anti-Human CEACAM-5/CD66e Recombinant Antibody (SAA0029)


View Antibody details